Class Name(s):
Pronunciation:
Brand Name(s):
Tirzepatide injection may may increase the risk that you will develop thyroid tumors, including a type of thyroid cancer. Tirzepatide injection caused thyroid tumors in rats. It is not known if this medication increases the risk of tumors in humans. Tell your doctor if you or anyone in your family has or ever had thyroid cancer or a condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) syndrome (condition that causes tumors in more than one gland in the body). If so, your doctor will probably tell you not to use tirzepatide injection. If you experience any of the following symptoms, call your doctor immediately: lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath.
Keep all appointments with your doctor and the laboratory. Your doctor may order certain tests to check your body's response to tirzepatide.
You will be given the Medication Guide when you begin treatment with tirzepatide and each time you refill your prescription. Read the information carefully and ask your doctor or pharmacist if you have any questions. You can also visit the Food and Drug Administration (FDA) website (http://www.fda.gov/Drugs/DrugSafety/ucm085729.htm) to obtain the Medication Guide.
Talk to your doctor about the risk of taking tirzepatide.
WHY is this medicine prescribed?
Tirzepatide injection is used for the following:
Tirzepatide is in a class of medications called incretin mimetics. It works by helping the pancreas to release the right amount of insulin when blood sugar levels are high. Insulin helps move sugar from the blood into other body tissues where it is used for energy. Tirzepatide injection also slows the emptying of the stomach and may decrease appetite and cause weight loss.
Over time, people who have diabetes and high blood sugar can develop serious or life-threatening complications, including heart disease, stroke, kidney problems, nerve damage, and eye problems. Using medication(s), making lifestyle changes (e.g., diet, exercise, quitting smoking), and regularly checking your blood sugar may help to manage your diabetes and improve your health. This therapy may also decrease your chances of having a heart attack, stroke, or other diabetes-related complications such as kidney failure, nerve damage (numb, cold legs or feet; decreased sexual ability in men and women), eye problems, including changes or loss of vision, or gum disease. Your doctor and other healthcare providers will talk to you about the best way to manage your diabetes.
HOW should this medicine be used?
Tirzepatide comes as a solution (liquid) in a pre-filled pen or vial to be injected subcutaneously (under the skin). It is injected once a week with or without meals at any time of day.
Use tirzepatide exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.
Your doctor will probably start you on a low dose of tirzepatide and gradually increase your dose, not more than once every 4 weeks.
Tirzepatide controls diabetes but does not cure it. It may take 4 weeks or longer before you feel the full benefit of tirzepatide. Continue to take tirzepatide even if you feel well. Do not stop taking tirzepatide without talking to your doctor.
You will be shown how to use the injection pen or vial by your doctor or nurse. You will also be given instructions for use with the medicine. This will tell you how to inject it. Read it carefully. Ask your pharmacist or doctor if you have any questions about how to inject this medication.
Tirzepatide can be injected in the abdomen, thigh or upper arm. Rotate injection sites with each dose.
You may change the day of the week you inject tirzepatide as long as at least 3 days have passed between doses.
You may administer insulin in the same area as tirzepatide but they should not be given right next to each other. Also, you should not mix tirzepatide and insulin in the same injection.
Always look at the tirzepatide solution before you inject it. It should be clear, colorless to slightly yelow and free of particles. Do not use semaglutide if it is colored (except slightly yellow), cloudy, frozen, or contains solid particles, or if the expiration date on the pen has passed.
Never reuse needles and never share needles or pens. Always remove the needle right after you inject your dose. Dispose of needles in a puncture-resistant container. Ask your doctor or pharmacist how to dispose of the puncture resistant container.
Are there OTHER USES for this medication?
This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.
What SPECIAL PRECAUTIONS should I follow?
Before taking tirzepatide,
What SPECIAL DIETARY instructions should I follow?
Unless your doctor tells you otherwise, continue your normal diet.
What should I do IF I FORGET to take a dose?
Inject the missed dose as soon as you remember it within 4 days after the missed dose. However, if more than 4 days have passed, skip the missed dose and continue your regular dosing schedule. Do not inject two doses within 3 days of each other.
What SIDE EFFECTS can this medicine cause?
Tirzepatide may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:
Some side effects can be serious. If you experience any of these symptoms or those listed in the IMPORTANT WARNING section, stop taking tirzepatide and call your doctor immediately:
Tirzepatide may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.
If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).
What should I do in case of OVERDOSE?
In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at http://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.
What should I know about STORAGE and DISPOSAL of this medication?
Tirzepatide should be stored in the refrigerator (between 36 to 46 degrees Fahrenheit). Keep tirzepatide in its original carton until use to protect from light. Single-dose pens or vials can be stored at room temperature for 21 days, if needed. Do not return the vials or pens to the refrigerator if previously stored at room temperature.
Keep all medication out of sight and reach of children as many containers are not child-resistant. Always lock safety caps. Place the medication in a safe location - one that is up and away and out of their sight and reach. http://www.upandaway.org
Dispose of unneeded medications in a way so that pets, children, and other people cannot take them. Do not flush this medication down the toilet. Use a medicine take-back program. Talk to your pharmacist about take-back programs in your community. Visit the FDA's Safe Disposal of Medicines website http://goo.gl/c4Rm4p for more information.
What OTHER INFORMATION should I know?
Keep all appointments with your doctor and the laboratory. Your doctor may order certain lab tests to check your body's response to tirzepatide.
Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.
Keep a written list of all of the prescription and nonprescription (over-the-counter) medicines, vitamins, minerals, and dietary supplements you are taking. Bring this list with you each time you visit a doctor or if you are admitted to the hospital. You should carry the list with you in case of emergencies.
This report on medications is for your information only, and is not considered individual patient advice. Because of the changing nature of drug information, please consult your physician or pharmacist about specific clinical use.
The American Society of Health-System Pharmacists, Inc. represents that the information provided hereunder was formulated with a reasonable standard of care, and in conformity with professional standards in the field. The American Society of Health-System Pharmacists, Inc. makes no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information and specifically disclaims all such warranties. Users are advised that decisions regarding drug therapy are complex medical decisions requiring the independent, informed decision of an appropriate health care professional, and the information is provided for informational purposes only. The entire monograph for a drug should be reviewed for a thorough understanding of the drug's actions, uses and side effects. The American Society of Health-System Pharmacists, Inc. does not endorse or recommend the use of any drug. The information is not a substitute for medical care.
AHFS® Patient Medication Information™ Copyright, 2025. The American Society of Health-System Pharmacists®, 4500 East-West Highway, Suite 900, Bethesda, Maryland. All Rights Reserved. Duplication for commercial use must be authorized by ASHP.
Selected Revisions: August 15, 2025.